Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SElf-SAMpling in Cervical Cancer Screening. SESAM Study; a Key to Better Health. Clinical Validation of a Self-sampling Device in Patients With Cervical Cancer and Cervical Pre-invasive Neoplasia

NCT02945891 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02945891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SElf-SAMpling in Cervical Cancer Screening. SESAM Study; a Key to Better Health. Clinical Validation of a Self-sampling Device in Patients With Cervical Cancer and Cervical Pre-invasive Neoplasia
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2014
Completion date
December 31, 2018
Enrollment
310 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer